Does TOPOTECAN Cause Neoplasm progression? 151 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 151 reports of Neoplasm progression have been filed in association with TOPOTECAN (HYCAMTIN). This represents 4.3% of all adverse event reports for TOPOTECAN.
151
Reports of Neoplasm progression with TOPOTECAN
4.3%
of all TOPOTECAN reports
54
Deaths
15
Hospitalizations
How Dangerous Is Neoplasm progression From TOPOTECAN?
Of the 151 reports, 54 (35.8%) resulted in death, 15 (9.9%) required hospitalization, and 19 (12.6%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 151 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TOPOTECAN Alternatives Have Lower Neoplasm progression Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE